Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential increase in endocannabinoid levels at the plasma and intracellular membranes.

iScience·2025
Same author

Behavioral Decoding Reveals Cortical Endocannabinoid Potentiation during Δ<sup>9</sup>-THC Impairment.

bioRxiv : the preprint server for biology·2025
Same author

Unraveling endocannabinoid signaling disruption in a preclinical model of neurodevelopmental disorders.

The Journal of clinical investigation·2025
Same author

The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Endocannabinoids facilitate transitory reward engagement through retrograde gain-control.

bioRxiv : the preprint server for biology·2025
Same author

Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia: a double-blind, placebo-controlled, randomized, crossover study.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2024

Related Experiment Video

Updated: May 8, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Chronic THC intake modifies fundamental cerebellar functions.

Nephi Stella1

  • 1Department of Pharmacology, University of Washington, Seattle, Washington 98195-7280, USA. nstella@uw.edu

The Journal of Clinical Investigation
|July 19, 2013
PubMed
Summary
This summary is machine-generated.

Subchronic intake of Delta9-tetrahydrocannabinol (THC) downregulates cannabinoid CB1 receptors in the cerebellum and activates microglia. This research raises new questions regarding the safety of regular THC consumption.

More Related Videos

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
04:05

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Related Experiment Videos

Last Updated: May 8, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
04:05

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cannabis Research

Background:

  • Delta9-tetrahydrocannabinol (THC) is the primary psychoactive compound in cannabis.
  • THC has diverse biological effects, including psychotropic and potential medicinal benefits.
  • Eyeblink reflexes are fundamental neuronal adaptive responses crucial for motor control.

Purpose of the Study:

  • To investigate the physiological consequences of subchronic THC intake on eyeblink reflexes.
  • To understand the impact of THC on cannabinoid CB1 receptor expression and microglial activation in the cerebellum.

Main Methods:

  • Utilized mouse genetics and classic mouse behavioral analysis.
  • Examined the effects of a subchronic THC regimen on neuronal and glial cells.

Main Results:

  • Subchronic THC intake led to the downregulation of cannabinoid CB1 receptors in cerebellar stress fibers.
  • Observed activation of microglia in the cerebellum following THC administration.
  • Demonstrated alterations in eyeblink reflexes, a fundamental neuronal adaptive response.

Conclusions:

  • Subchronic THC intake alters cerebellar cannabinoid CB1 receptor expression and induces microglial activation.
  • Findings suggest potential neuroinflammatory effects associated with regular THC use.
  • Raises important questions about the long-term safety profile of therapeutic or recreational THC regimens.